Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Crinetics Pharmaceuticals
(CRNX) Q2 2026
Earnings
CRNX
May 7
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.38
-1.23
-1.09
-0.94
Details
Expected EPS
-1.221429
Actual EPS
-1.23
Surprise EPS
-0.01
Surprise Percent
-0.7%
Description
Crinetics Pharmaceuticals (CRNX) has reported earnings of -1.23 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login